Vakula Connect is our regular update for consultants deciding where to take their next assignment and for clients planning their next programme. This edition covers Q4 2023.
Market signals
- DHS proposed the H-1B modernisation rule in October, with beneficiary-centric selection and new third-party placement provisions that affect staffing arrangements.
- Device manufacturers began budgeting for QMSR alignment ahead of FDA's final rule expected early in 2024.
- Year-end saw the usual extension cycle, with stronger-than-usual demand for pharmacovigilance and regulatory roles.
Roles in demand this quarter
Titles that recurred in client requisitions: Regulatory Affairs Associate, Pharmacovigilance Scientist, Quality Assurance Manager (devices), Project Manager (IT). Current openings are always on our careers page.
Signal to leaders
The disciplines that were hardest to fill were the ones where clients needed judgement as well as capacity; briefing for the judgement shortened time-to-fill.
At Vakula
We updated placement documentation to reflect the proposed H-1B rule and prepared QMSR gap-assessment offerings for device clients. Two full years in, the engagement model had not changed: terms in writing before interview, a named engagement lead on every placement.
For consultants
Rate, duration, location and client are disclosed before you decide to interview; you get feedback after every submission; there are no fees to candidates at any stage. Send your resume.
For clients
Send one requisition and judge the shortlist. Start here.
Join the conversation
Tell us what you are working through at info@vakulatech.com; we may feature the question in a future edition.